Literature DB >> 17275549

Systemic corticosteroids for allergic fungal rhinosinusitis and chronic rhinosinusitis with nasal polyposis: a comparative study.

Roee Landsberg1, Yoram Segev, Ari DeRowe, Tali Landau, Avi Khafif, Dan M Fliss.   

Abstract

OBJECTIVES: To compare the effect of preoperative high-dose systemic corticosteroids on the radiographic and endoscopic appearance of allergic fungal rhinosinusitis (AFRS) and chronic rhinosinusitis with nasal polyposis (CRSwNP). STUDY DESIGN AND
SETTING: Eight AFRS and 10 CRSwNP patients underwent computed tomographic (CT) scans and then received preoperative 1 mg/kg prednisone for 10 days. CT scans were repeated 1 day before surgery and compared with pretreatment scans (Lund-MacKay radiologic scoring system). The endoscopic appearance was recorded intraoperatively.
RESULTS: The score dropped from 16 (66.4%) to 4.75 in the AFRS group and from 18.4 (23%) to 14.1 in the CRSwNP group (P=0.0064). Intraoperatively, most sinus mucosal surfaces appeared normal in the AFRS patients but were markedly edematous in the CRSwNP patients.
CONCLUSION: Radiographic response of AFRS to systemic corticosteroids is significantly greater compared with CRSwNP. This finding is supported by endoscopic observation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17275549     DOI: 10.1016/j.otohns.2006.09.010

Source DB:  PubMed          Journal:  Otolaryngol Head Neck Surg        ISSN: 0194-5998            Impact factor:   3.497


  10 in total

Review 1.  Comprehensive review on endonasal endoscopic sinus surgery.

Authors:  Rainer K Weber; Werner Hosemann
Journal:  GMS Curr Top Otorhinolaryngol Head Neck Surg       Date:  2015-12-22

2.  Effect of prednisone on nasal symptoms and peripheral blood T-cell function in chronic rhinosinusitis.

Authors:  So Watanabe; Jayant M Pinto; Mohamed Elfatih H Bashir; Marcella De Tineo; Harumi Suzaki; Fuad M Baroody; Robert M Naclerio; Shilpy Sharma
Journal:  Int Forum Allergy Rhinol       Date:  2014-04-21       Impact factor: 3.858

Review 3.  Optimal Management of Allergic Fungal Rhinosinusitis.

Authors:  Gaurav Medikeri; Amin Javer
Journal:  J Asthma Allergy       Date:  2020-09-11

Review 4.  Oral steroid therapy in chronic rhinosinusitis with and without nasal polyposis.

Authors:  Brittany E Howard; Devyani Lal
Journal:  Curr Allergy Asthma Rep       Date:  2013-04       Impact factor: 4.806

5.  Glucocorticoid receptor isoform expression in peripheral blood mononuclear leukocytes of patients with chronic rhinosinusitis.

Authors:  Robert J Taylor; Rodney J Schlosser; Zachary M Soler; Jose L Mattos; Jennifer K Mulligan
Journal:  Int Forum Allergy Rhinol       Date:  2018-05-02       Impact factor: 3.858

Review 6.  Allergic Fungal Rhinosinusitis in Saudi Arabia: A Review of Recent Literature.

Authors:  Abdussalam A AlAhmari
Journal:  Cureus       Date:  2021-12-25

7.  Allergic fungal rhinosinusitis presenting with intracranial spread along large sphenoidal emissary foramen.

Authors:  Robert R Lisac; Matthew Garber; Ayesha Mirza; Chetan C Shah
Journal:  Med Mycol Case Rep       Date:  2021-01-11

8.  Update on the management of chronic rhinosinusitis.

Authors:  Rachel B Cain; Devyani Lal
Journal:  Infect Drug Resist       Date:  2013-01-23       Impact factor: 4.003

Review 9.  Allergic Aspergillus Rhinosinusitis.

Authors:  Arunaloke Chakrabarti; Harsimran Kaur
Journal:  J Fungi (Basel)       Date:  2016-12-08

Review 10.  Benefits and harm of systemic steroids for short- and long-term use in rhinitis and rhinosinusitis: an EAACI position paper.

Authors:  Valerie Hox; Evelijn Lourijsen; Arnout Jordens; Kristian Aasbjerg; Ioana Agache; Isam Alobid; Claus Bachert; Koen Boussery; Paloma Campo; Wytske Fokkens; Peter Hellings; Claire Hopkins; Ludger Klimek; Mika Mäkelä; Ralph Mösges; Joaquim Mullol; Laura Pujols; Carmen Rondon; Michael Rudenko; Sanna Toppila-Salmi; Glenis Scadding; Sophie Scheire; Peter-Valentin Tomazic; Thibaut Van Zele; Martin Wagemann; Job F M van Boven; Philippe Gevaert
Journal:  Clin Transl Allergy       Date:  2020-01-03       Impact factor: 5.871

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.